Cancer Diagnostics

Cancer Diagnostics is a private U.S. anatomic pathology and histology products company that develops, manufactures, and supplies diagnostic consumables, reagents, and laboratory equipment for pathology workflows. Founded in 1998, the company is best known for its tissue marking dyes, including what it describes as the first commercially available 7-dye color system for marking tissue margins. Its portfolio spans histology, cytology, surgical pathology, immunohistochemistry, fixatives, stains, microarrays, waxes, blades, specimen handling products, and related laboratory equipment. The business serves pathology laboratories and other clinical and research customers globally, with thousands of customers and a broad catalog of products rather than a therapeutic drug pipeline. Cancer Diagnostics also acquired Anatech to expand its pathology consumables and staining-related offerings.